AI Tool for Early Detection of Parkinson’s Disease Using Voice Analysis
AI tool analyzes voice to detect early signs of Parkinson’s disease with 86% accuracy. Accessible screening method. π§ π€
August 8, 2025
Follow us
latest articles
Discover the newest research about AI innovations in π§ Neuroscience.
Development of LRRK2 inhibitors through computational strategies: a promising avenue for Parkinson’s disease.
Exploring LRRK2 inhibitors for Parkinson’s: AI-driven strategies show promise in drug discovery. π§ π
August 7, 2025
Implication of Bimodal Magnetic Resonance and Fluorescence Imaging Probes in Advanced Healthcare: Enhancing Disease Diagnosis and Targeted Therapy.
Bimodal imaging probes enhance disease diagnosis and therapy, combining MRI and fluorescence for improved precision. π§¬π¬
August 4, 2025
Collaboration Between UHL, UHN, and Microsoft to Enhance AI in Healthcare
UHL, UHN, and Microsoft partner to advance AI in healthcare, aiming to improve patient care and streamline services. π€π»
July 31, 2025
Integrating chemical artificial intelligence and cognitive computing for predictive analysis of biological pathways: a case for intrinsically disordered proteins.
Exploring AI’s role in predicting biological pathways through intrinsically disordered proteins. π€π§¬ Key insights from recent research!
July 30, 2025
An explainable transformer model for Alzheimer’s disease detection using retinal imaging.
Revolutionary Retformer model detects Alzheimer’s via retinal imaging, outperforming benchmarks by 11%! π§ ποΈ
July 24, 2025
Mayo Clinic Develops AI Tool for Identifying Multiple Types of Dementia
Mayo Clinic’s AI tool identifies nine dementia types, including Alzheimer’s, improving diagnosis accuracy and speed. π§ π‘
July 23, 2025
Sora Neuroscience’s Cirrus Brain Mapping Software Receives FDA Approval
Sora Neuroscience’s Cirrus brain mapping software has received FDA approval, aiding neurosurgeons in surgical planning. π§ β
June 30, 2025
AI-Driven Discovery of Brain-Penetrant Galectin-3 Inhibitors for Alzheimer’s Disease Therapy.
AI identifies FJMU1887, a Gal-3 inhibitor, enhancing cognition and reducing neuroinflammation in Alzheimer’s models. π§ π
June 23, 2025
Applications of artificial intelligence in drug discovery for neurological diseases.
AI revolutionizes drug discovery for neurological diseases, enhancing molecule identification and treatment potential. π€π
June 19, 2025